Not precisely. Although both focus on GLP-one receptors, Tirz also activates GIP receptors, making it a twin agonist. This broader mechanism is thought to enhance its outcomes on insulin sensitivity and appetite signaling in exploration products. El reto farmacológico de esta clase de moléculas es el equilibrium entre las tres https://peptisell.com/